blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3539548

EP3539548 - COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY CELLS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  27.03.2020
Database last updated on 20.03.2026
FormerGrant of patent is intended
Status updated on  26.02.2020
FormerExamination is in progress
Status updated on  17.08.2019
FormerRequest for examination was made
Status updated on  16.08.2019
Most recent event   Tooltip12.03.2026Change: Decision (+date) in appeal procedure 
12.03.2026New entry: Decision (+date) in appeal procedure 
Applicant(s)For all designated states
The University of Tokyo
3-1, Hongo 7-chome
Bunkyo-ku
Tokyo 113-8654 / JP
[2019/38]
Inventor(s)01 / HONDA, Kenya
RIKEN Center for Integrative Medical Sciences (IMS
RCAI)
Laboratory for Gut Homeostasis
1-7-22 Suehiro-cho, Tsurumi-ku
Yokohama, 230-0045 / JP
02 / ATARASHI, Koji
RIKEN Center for Integrative Medical Sciences (IMS
RCAI)
Laboratory for Gut Homeostasis
1-7-22 Suehiro-cho, Tsurumi-ku
Yokohama, 230-0045 / JP
03 / ITOH, Kikuji
Laboratory for Gut Homeostasis
RIKEN Center for Integrative Medical Sciences
(IMS RCAI)
1-7-22 Suehiro-cho, Tsurumi-ku
Yokohama 230-0045 / JP
04 / TANOUE, Takeshi
RIKEN Center for Integrative Medical Sciences (IMS
RCAI)
Laboratory for Gut Homeostasis
1-7-22 Suehiro-cho, Tsurumi-ku
Yokohama, 230-0045 / JP
 [2019/45]
Former [2019/38]01 / Honda, Kenya
RIKEN Center for Integrative Medical Sciences (IMS
RCAI)
Laboratory for Gut Homeostasis
1-7-22 Suehiro-cho, Tsurumi-ku
Yokohama, 230-0045 / JP
02 / Atarashi, Koji
RIKEN Center for Integrative Medical Sciences (IMS
RCAI)
Laboratory for Gut Homeostasis
1-7-22 Suehiro-cho, Tsurumi-ku
Yokohama, 230-0045 / JP
03 / Itoh, Kikuji
c/o THE UNIVERSITY OF TOKYO
3-1, Hongo 7-chome
Bunkyo-ku
Tokyo, 113-8654 / JP
04 / Tanoue, Takeshi
RIKEN Center for Integrative Medical Sciences (IMS
RCAI)
Laboratory for Gut Homeostasis
1-7-22 Suehiro-cho, Tsurumi-ku
Yokohama, 230-0045 / JP
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2019/38]
Application number, filing date19168383.803.06.2011
[2019/38]
Priority number, dateJP2010012913404.06.2010         Original published format: JP 2010129134
WO2010JP7174603.12.2010         Original published format: PCT/JP2010/071746
[2019/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3539548
Date:18.09.2019
Language:EN
[2019/38]
Type: B1 Patent specification 
No.:EP3539548
Date:29.04.2020
Language:EN
[2020/18]
Search report(s)(Supplementary) European search report - dispatched on:EP26.07.2019
ClassificationIPC:A61K35/742
[2019/38]
CPC:
A61K39/39 (EP,US); A61K35/742 (US); A01K67/0275 (EP,US);
A61K35/74 (EP,US); A61K39/0008 (US); A61K39/08 (US);
A61K45/00 (US); A61K45/06 (EP,US); A61K9/0053 (US);
A61K9/48 (US); A61P1/00 (EP); A61P1/04 (EP);
A61P1/12 (EP); A61P19/02 (EP); A61P25/00 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P31/00 (EP);
A61P31/04 (EP); A61P37/00 (EP); A61P37/02 (EP);
A61P37/04 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P43/00 (EP); C12Q1/689 (US); G01N33/505 (EP,US);
A01K2217/072 (EP); A01K2217/203 (EP); A01K2227/105 (EP);
A01K2267/0325 (EP,US); A61K2039/52 (US); A61K2039/542 (US);
A61K2039/55594 (EP,US); A61K2039/57 (US); A61K2039/577 (EP);
A61K35/00 (EP,US); C12Q2600/158 (US); G01N2333/33 (EP,US);
G01N2500/10 (EP,US) (-)
C-Set:
A61K35/74, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/38]
TitleGerman:ZUSAMMENSETZUNG ZUR INDUZIERUNG DER PROLIFERATION ODER AKKUMULATION VON REGULATORISCHEN ZELLEN[2019/38]
English:COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY CELLS[2019/38]
French:COMPOSITION POUR INDUIRE LA PROLIFÉRATION OU L'ACCUMULATION DE CELLULES RÉGULATRICES[2019/38]
Examination procedure10.04.2019Examination requested  [2019/38]
26.07.2019Date on which the examining division has become responsible
21.08.2019Despatch of a communication from the examining division (Time limit: M04)
25.11.2019Reply to a communication from the examining division
27.02.2020Communication of intention to grant the patent
18.03.2020Fee for grant paid
18.03.2020Fee for publishing/printing paid
18.03.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP11728077.6  / EP2575835
EP16188203.0  / EP3178483
Opposition(s)Opponent(s)01  29.01.2021  02.02.2021  ADMISSIBLE
Société des Produits Nestlé S.A.
Avenue Nestlé 55
1800 Vevey / CH
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
 02  29.01.2021  02.02.2021  ADMISSIBLE
Rieck, Markus
Die Rappenwiesen 25
61350 Bad Homburg / DE
Opponent's representative
Fuchs Patentanwälte Partnerschaft mbB
Tower 185
Friedrich-Ebert-Anlage 35-37
60327 Frankfurt am Main / DE
 03  29.01.2021  02.02.2021  ADMISSIBLE
Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
 04  29.01.2021  02.02.2021  WITHDRAWN
STRAWMAN LIMITED
Orchard Lea
Horns Lane
Combe
Witney, Oxfordshire OX29 8NH / GB
 [2024/19]
Former [2024/18]
Opponent(s)01  29.01.2021  02.02.2021  ADMISSIBLE
Société des Produits Nestlé S.A.
Avenue Nestlé 55
1800 Vevey / CH
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
 02  29.01.2021  02.02.2021  ADMISSIBLE
Rieck, Markus
Die Rappenwiesen 25
61350 Bad Homburg / DE
Opponent's representative
Fuchs Patentanwälte Partnerschaft mbB
Tower 185
Friedrich-Ebert-Anlage 35-37
60327 Frankfurt am Main / DE
 03  29.01.2021  02.02.2021  ADMISSIBLE
Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
 04  29.01.2021  02.02.2021  ADMISSIBLE
STRAWMAN LIMITED
Orchard Lea
Horns Lane
Combe
Witney, Oxfordshire OX29 8NH / GB
Former [2024/10]
Opponent(s)01  29.01.2021  02.02.2021  ADMISSIBLE
Société des Produits Nestlé S.A.
Avenue Nestlé 55
1800 Vevey / CH
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
 02  29.01.2021  02.02.2021  ADMISSIBLE
Rieck, Markus
Die Rappenwiesen 25
61350 Bad Homburg / DE
Opponent's representative
Fuchs Patentanwälte Partnerschaft mbB
Tower 185
Friedrich-Ebert-Anlage 35-37
60327 Frankfurt am Main / DE
 03  29.01.2021  02.02.2021  ADMISSIBLE
Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
 04  29.01.2021  02.02.2021  ADMISSIBLE
STRAWMAN LIMITED
Orchard Lea
Horns Lane
Combe
Witney, Oxfordshire OX29 8NH / GB
Former [2021/10]
Opponent(s)01  29.01.2021  02.02.2021  ADMISSIBLE
Société des Produits Nestlé S.A.
Avenue Nestlé 55
1800 Vevey / CH
Opponent's representative
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
 02  29.01.2021  02.02.2021  ADMISSIBLE
Rieck, Markus
Die Rappenwiesen 25
61350 Bad Homburg / DE
Opponent's representative
Fuchs Patentanwälte Partnerschaft mbB
Westhafenplatz 1
60327 Frankfurt am Main / DE
 03  29.01.2021  02.02.2021  ADMISSIBLE
Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
 04  29.01.2021  02.02.2021  ADMISSIBLE
STRAWMAN LIMITED
Orchard Lea
Horns Lane
Combe
Witney, Oxfordshire OX29 8NH / GB
Opponent's representative
Brand Murray Fuller LLP
50 Eastcastle Street
London W1W 8EA / GB
deletedDeletion: Legal effect of rejection of opposition [ N /P ]
10.02.2021Invitation to proprietor to file observations on the notice of opposition
20.07.2021Reply of patent proprietor to notice(s) of opposition
16.10.2023Date of oral proceedings
13.11.2023Despatch of minutes of oral proceedings
13.11.2023Date of despatch of rejection of opposition
Appeal following opposition15.01.2024Appeal received No.  T0100/24
15.01.2024Payment of appeal fee
13.03.2024Statement of grounds filed
10.03.2026Result of appeal procedure: REVOCATION OF PATENT AT PROPRIETOR'S REQUEST
18.03.2026Despatch of the decision of the Board of Appeal
12.01.2024Appeal received No.  T0100/24
12.01.2024Payment of appeal fee
12.03.2024Statement of grounds filed
10.03.2026Result of appeal procedure: REVOCATION OF PATENT AT PROPRIETOR'S REQUEST
18.03.2026Despatch of the decision of the Board of Appeal
10.03.2026Date of oral proceedings
Fees paidRenewal fee
10.04.2019Renewal fee patent year 03
10.04.2019Renewal fee patent year 04
10.04.2019Renewal fee patent year 05
10.04.2019Renewal fee patent year 06
10.04.2019Renewal fee patent year 07
10.04.2019Renewal fee patent year 08
10.04.2019Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.06.2011
AL29.04.2020
AT29.04.2020
CY29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
MK29.04.2020
MT29.04.2020
RO29.04.2020
RS29.04.2020
SI29.04.2020
SK29.04.2020
SM29.04.2020
TR29.04.2020
IE03.06.2020
LU03.06.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
[2023/41]
Former [2022/33]HU03.06.2011
AL29.04.2020
AT29.04.2020
CY29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
MK29.04.2020
MT29.04.2020
RO29.04.2020
RS29.04.2020
SK29.04.2020
SM29.04.2020
TR29.04.2020
IE03.06.2020
LU03.06.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2022/27]HU03.06.2011
AL29.04.2020
AT29.04.2020
CY29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
MT29.04.2020
RO29.04.2020
RS29.04.2020
SK29.04.2020
SM29.04.2020
TR29.04.2020
IE03.06.2020
LU03.06.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/20]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
RO29.04.2020
RS29.04.2020
SK29.04.2020
SM29.04.2020
IE03.06.2020
LU03.06.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/15]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
RO29.04.2020
RS29.04.2020
SK29.04.2020
SM29.04.2020
LU03.06.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/10]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
RO29.04.2020
RS29.04.2020
SK29.04.2020
SM29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/09]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
RO29.04.2020
RS29.04.2020
SM29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/08]AL29.04.2020
DK29.04.2020
FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
RO29.04.2020
RS29.04.2020
SM29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/04]AL29.04.2020
FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
RS29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/01]FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
RS29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2020/51]FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
RS29.04.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2020/50]FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2020/48]FI29.04.2020
LT29.04.2020
NO29.07.2020
IS29.08.2020
PT31.08.2020
Former [2020/47]LT29.04.2020
NO29.07.2020
IS29.08.2020
Former [2020/46]IS29.08.2020
Documents cited:Search[A] EP1955706  (CT INGENIERIA GENETICA BIOTECH et al.)
 [A] EP1749538  (KIRIN BREWERY et al.)
 [A] WO2009050486  (UNIV SURREY et al.)
 [A] DE102006062250  (SAUR-BROSCH ROLAND et al.)
 [A]   VALERIE GABORIAU-ROUTHIAU ET AL: "The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell Responses", IMMUNITY, vol. 31, no. 4, 1 October 2009 (2009-10-01), pages 677 - 689, XP055005245, ISSN: 1074-7613, DOI: 10.1016/j.immuni.2009.08.020

DOI:   http://dx.doi.org/10.1016/j.immuni.2009.08.020
 [A]   SOKOL HARRY ET AL: "Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients", PNAS, NATIONAL ACADEMY OF SCIENCES, US, vol. 105, no. 43, 28 October 2008 (2008-10-28), pages 16731 - 16736, XP002579466, ISSN: 0027-8424, [retrieved on 20081020], DOI: 10.1073/PNAS.0804812105

DOI:   http://dx.doi.org/10.1073/PNAS.0804812105
 [A]   K. KARIMI ET AL: "Lactobacillus reuteri-induced Regulatory T cells Protect against an Allergic Airway Response in Mice", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, vol. 179, no. 3, 1 February 2009 (2009-02-01), pages 186 - 193, XP055005126, ISSN: 1073-449X, DOI: 10.1164/rccm.200806-951OC

DOI:   http://dx.doi.org/10.1164/rccm.200806-951OC
 [A]   ITOH K ET AL: "Characterization of clostridia isolated from faeces of limited flora mice and their effect on caecal size when associated with germ-free mice", LABORATORY ANIMALS, LABORATORY ANIMALS, LONDON, GB, vol. 19, no. 2, 1 April 1985 (1985-04-01), pages 111 - 118, XP002657282, ISSN: 0023-6772
 [A]   T. CLAVEL ET AL: "Survival of Bacillus cereus spores and vegetative cells in acid media simulating human stomach", JOURNAL OF APPLIED MICROBIOLOGY., vol. 97, no. 1, 1 July 2004 (2004-07-01), GB, pages 214 - 219, XP055365130, ISSN: 1364-5072, DOI: 10.1111/j.1365-2672.2004.02292.x

DOI:   http://dx.doi.org/10.1111/j.1365-2672.2004.02292.x
 [T]   K. ATARASHI ET AL: "Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species", SCIENCE, vol. 331, no. 6015, 21 January 2011 (2011-01-21), pages 337 - 341, XP055005026, ISSN: 0036-8075, DOI: 10.1126/science.1198469

DOI:   http://dx.doi.org/10.1126/science.1198469
 [T]   KOJI ATARASHI ET AL: "Microbiotal influence on T cell subset development", SEMINARS IN IMMUNOLOGY, vol. 23, no. 2, 1 April 2011 (2011-04-01), pages 146 - 153, XP055005114, ISSN: 1044-5323, DOI: 10.1016/j.smim.2011.01.010

DOI:   http://dx.doi.org/10.1016/j.smim.2011.01.010
by applicantUS6368586
   J. J. CEBRA, AM J CLIN NUTR, vol. 69, May 1999 (1999-05-01), pages 1046S
   A. J. MACPHERSON; N. L. HARRIS, NAT REV IMMUNOL, vol. 4, June 2004 (2004-06-01), pages 478
   J. L. ROUND; S. K. MAZMANIAN, NAT REV IMMUNOL, vol. 9, May 2009 (2009-05-01), pages 313
   D. BOUSKRA ET AL., NATURE, vol. 456, 27 November 2008 (2008-11-27), pages 507
   K. ATARASHI ET AL., NATURE, vol. 455, 9 October 2008 (2008-10-09), pages 808
   IVANOV, II ET AL., CELL HOST MICROBE, vol. 4, 16 October 2008 (2008-10-16), pages 337
   S. L. SANOS ET AL., NAT IMMUNOL, vol. 10, January 2009 (2009-01-01), pages 83
   M. A. CUROTTO DE LAFAILLE; J. J. LAFAILLE, IMMUNITY, vol. 30, May 2009 (2009-05-01), pages 626
   M. J. BARNES; F. POWRIE, IMMUNITY, vol. 31, 18 September 2009 (2009-09-18), pages 401
   W. S. GARRETT ET AL., CELL, vol. 131, 5 October 2007 (2007-10-05), pages 33
   IVANOV, II ET AL., CELL, vol. 139, 30 October 2009 (2009-10-30), pages 485
   V. GABORIAU-ROUTHIAU ET AL., IMMUNITY, vol. 31, 16 October 2009 (2009-10-16), pages 677
   N. H. SALZMAN ET AL., NAT IMMUNOL, vol. 11, pages 76
   K. M. MASLOWSKI ET AL., NATURE, vol. 461, 29 October 2009 (2009-10-29), pages 1282
   L. F. LU; A. RUDENSKY, GENES DEV, vol. 23, 1 June 2009 (2009-06-01), pages 1270
   S. SAKAGUCHI; T. YAMAGUCHI; T. NOMURA, CELL, vol. 133, 30 May 2008 (2008-05-30), pages 775
   C. L. MAYNARD ET AL., NAT IMMUNOL, vol. 8, September 2007 (2007-09-01), pages 931
   Y. P. RUBTSOV ET AL., IMMUNITY, vol. 28, April 2008 (2008-04-01), pages 546
   ITOH, K.; MITSUOKA, T.: "Characterization of clostridia isolated from faeces of limited flora mice and their effect on caecal size when associated with germ-free mice", LAB. ANIMALS, vol. 19, 1985, pages 111 - 118, XP002657282
   S. WIRTZ; C. NEUFERT; B. WEIGMANN; M. F. NEURATH, NAT PROTOC, vol. 2, 2007, pages 541
   RAKOFF-NAHOUM, J. PAGLINO; F. ESLAMI-VARZANEH; S. EDBERG; R. MEDZHITOV, CELL, vol. 118, 23 July 2004 (2004-07-23), pages 229
   FAGARASAN ET AL., SCIENCE, vol. 298, 15 November 2002 (2002-11-15), pages 1424
   M. N. KWEON ET AL., J IMMUNOL, vol. 174, 1 April 2005 (2005-04-01), pages 4365
   HONDA ET AL., J EXP MED, vol. 193, 5 March 2001 (2001-03-05), pages 621
   T. AEBISCHER ET AL.: "Vaccination prevents Helicobacter pylori-induced alterations of the gastric flora in mice", FEMS IMMUNOL. MED. MICROBIOL., vol. 46, 2006, pages 221 - 229
   A. M. THORNTON ET AL., J IMMUNOL, vol. 184, 1 April 2010 (2010-04-01), pages 3433
   D'ANGELO ET AL., J. BIOL. CHEM., vol. 276, 2001, pages 11347 - 11353
   HEIDINGER ET AL., BIOL. CHEM., vol. 387, 2006, pages 69 - 78
   YU ET AL., GENES DEV., vol. i4, 2000, pages 163 - 176
   G. MATTEOLI ET AL., GUT, vol. 59, May 2010 (2010-05-01), pages 595
   S. MANICASSAMY ET AL., SCIENCE, vol. 329, 13 August 2010 (2010-08-13), pages 849
   M. BOIRIVANT; I. J. FUSS; A. CHU; W. STROBER, J EXP MED, vol. 188, 16 November 1998 (1998-11-16), pages 1929
OppositionUS5599795
 EP2575835
 EP3539548
 WO2004085628
 WO2013080561
 JP2009084215
 EP1955706
 EP1749538
 WO2009050486
 DE102006062250
 US5599795
   KROGIUS-KURIKKA LOTTA; KASSINEN ANNA; PAULIN LARS; CORANDER JUKKA; MKIVUOKKO HARRI; TUIMALA JARNO; PALVA AIRI: "Sequence analysis of percent G+C fraction libraries of human faecal bacterial DNA reveals a high number of Actinobacteria", B MC MICROBIOLOGY, vol. 9, no. 68, 2009, pages 1 - 13, XP021048239

DOI:   http://dx.doi.org/10.1186/1471-2180-9-68
   BRUCE ROBERTS: "Generation and Development of Defined Microbial Drug", VEDANTA BIOSCIENCES, 28 June 2016 (2016-06-28), pages 1 - 17, XP055777307
   ATARASHI K; TANOUE T; SHIMA T; IMAOKA A; KUWAHARA T; MOMOSE Y; CHENG G; YAMASAKI S; SAITO T; OHBA Y; TANIGUCHI T; TAKEDA K; HORI S: "Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species", NIH PUBLIC ACCESS AUTHOR MANUSCRIPT,, vol. 331, no. 6015, 2011, pages 337 - 341, XP055598571

DOI:   http://dx.doi.org/10.1126/science.1198469
   ATARASHI K; TANOUE T; SHIMA T; IMAOKA A; KUWAHARA T; MOMOSE Y; CHENG G; YAMASAKI S; SAITO T; OHBA Y; TANIGUCHI T; TAKEDA K; HORI S: "Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species - Supporting Online Material", SCIENCE, vol. 331, 23 December 2010 (2010-12-23), pages 337 - 341, XP055178447

DOI:   http://dx.doi.org/10.1126/science.1198469
   KELLY D; CONWAY S; AMINOV R: "Commensal gut bacteria: mechanisms of immune modulation", TRENDS IN IMMUNOLOGY, vol. 26, no. 6, 2005, pages 326 - 333, XP004912101

DOI:   http://dx.doi.org/10.1016/j.it.2005.04.008
   KOJI ATARASHI; TAKESHI TANOUE; KENSHIRO OSHIMA; WATARU SUDA; YUJI NAGANO; HIROYOSHI NISHIKAWA; SHINJI FUKUDA; TAKURO SAITO; SEIKO : "Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota", NATURE, vol. 500, no. 7461, 2013, pages 232 - 236, XP055178303

DOI:   http://dx.doi.org/10.1038/nature12331
   ITOH K; MITSUOKA T: "Characterization of clostridia isolated from faeces of limited flora mice and their effect on caecal size when associated with germ-free mice", LABORATORY ANIMALS, vol. 19, 1985, pages 111 - 118, XP002657282
   KOJI ATARASHI, TAKESHI TANOUE, KENYA HONDA: "Poster 064-03: Regulation of colonic regulatory T cells by Clostridium species", 22 August 2010 (2010-08-22)
   BORODY T J; ET AL: "Treatment of ulcerative colitis using fecal bacteriotherapy", J CLIN GASTROENTEROL, vol. 37, no. 1, 2003, pages 42 - 47, XP008093566

DOI:   http://dx.doi.org/10.1097/00004836-200307000-00012
   ZHOU ET AL.: "Total fecal microbiota transplantation alleviates highfat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota", SCIENTIFIC REPORTS, vol. 7, no. 1529, 8 May 2017 (2017-05-08), pages 1 - 11, XP055402631
   KAKIHANA ET AL.: "Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut", BLOOD, vol. 128, no. 16, 2016, pages 2083 - 2087, XP055402621

DOI:   http://dx.doi.org/10.1182/blood-2016-05-717652
   VALRIE GABORIAU-ROUTHIAU, SABINE RAKOTOBE, EMELYNE LCUYER, IMKE MULDER, ANNAG LAN, CHANTAL BRIDONNEAU, VIOLAINE ROCHET, ANNAMAR: "The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell Responses", IMMUNITY, CELL PRESS, vol. 31, no. 4, 1 October 2009 (2009-10-01), pages 677 - 689, XP055005245, ISSN: 10747613, DOI: 10.1016/j.immuni.2009.08.020

DOI:   http://dx.doi.org/10.1016/j.immuni.2009.08.020
   BRAAT, H. ROTTIERS, P. HOMMES, D.W. HUYGHEBAERT, N. REMAUT, E. REMON, J. VAN DEVENTER, S.J.H. NEIRYNCK, S. PEPPELE: "A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn's Disease", CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 4, no. 6, 1 June 2006 (2006-06-01), AMSTERDAM, NL, pages 754 - 759, XP005476580, ISSN: 1542-3565, DOI: 10.1016/j.cgh.2006.03.028

DOI:   http://dx.doi.org/10.1016/j.cgh.2006.03.028
   KARIMI ET AL.: "Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice", AM. J. RESPIR. CRIT. CARE MED., vol. 179, 2009, pages 186 - 193, XP055005126, DOI: 10.1164/rccm.200806-951OC

DOI:   http://dx.doi.org/10.1164/rccm.200806-951OC
   VAN IMMERSEEL FILIP, ET AL: "Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease", JOURNAL OF MEDICAL MICROBIOLOGY, CHURCHILL LIVINGSTONE [ETC.], vol. 59, no. 2, 1 February 2010 (2010-02-01), pages 141 - 143, XP002579463, ISSN: 0022-2615, DOI: 10.1099/JMM.0.017541-0

DOI:   http://dx.doi.org/10.1099/JMM.0.017541-0
   JANEWAY C A ,TRAVERS P: "Immunobiology: The Immune System in Health and Disease", CURRENT BIOLOGY, CURRENT SCIENCE, GB, 1 January 1994 (1994-01-01), GB , pages 1140 - 1141, XP002193387, ISSN: 0960-9822
   COLLINS ET AL.: "The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations", INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1994, pages 812 - 826, XP055107539, DOI: 10.1099/00207713-44-4-812

DOI:   http://dx.doi.org/10.1099/00207713-44-4-812
   ORIANA ROSSI, LISETTE A. VAN BERKEL, FLORIAN CHAIN, M. TANWEER KHAN, NICO TAVERNE, HARRY SOKOL, SYLVIA H. DUNCAN, HARRY J. FLINT, : "Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses", SCIENTIFIC REPORTS, vol. 6, pages 18507, XP055351788, DOI: 10.1038/srep18507

DOI:   http://dx.doi.org/10.1038/srep18507
   MING-CAILI SHAO-HENGHE, SHAO-HENG HE: "IL-10 and its related cytokines for treatment of inflammatory bowel disease", 世界胃肠病学杂志：英文版, CHINA, 1 January 2004 (2004-01-01), China , pages 620 - 625, XP055484731, Retrieved from the Internet DOI: 10.3748/wjg.v10.i5.620

DOI:   http://dx.doi.org/10.3748/wjg.v10.i5.620
   STEIDLER ET AL.: "Treatment of murine colitis by Lactococcus lactis secreting interleukin-10", SCIENCE, vol. 289, 2000, pages 1352 - 1355, XP002208404, DOI: 10.1126/science.289.5483.1352

DOI:   http://dx.doi.org/10.1126/science.289.5483.1352
   VAN MONTFRAN S ET AL.: "Prevention of colitis by interleukin 10- transduced T lymphocytes in the SCID mice transfer model", GASTROENTEROLO- GY, vol. 123, 2002, pages 1865 - 1876, XP029482906, DOI: 10.1053/gast.2002.37067

DOI:   http://dx.doi.org/10.1053/gast.2002.37067
   VAN MONTFRANS ET AL.: "Generation of regulatory gut-homing human T lymphocytes using ex vivo interleukin 10 gene transfer", GASTROENTEROLOGY, vol. 123, 2002, pages 1877 - 1888, XP009010755, DOI: 10.1053/gast.2002.37066

DOI:   http://dx.doi.org/10.1053/gast.2002.37066
   K. ATARASHI, T. TANOUE, T. SHIMA, A. IMAOKA, T. KUWAHARA, Y. MOMOSE, G. CHENG, S. YAMASAKI, T. SAITO, Y. OHBA, T. TANIGUCHI, K. TA: "Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, vol. 331, no. 6015, 21 January 2011 (2011-01-21), pages 337 - 341, XP055005026, ISSN: 00368075, DOI: 10.1126/science.1198469

DOI:   http://dx.doi.org/10.1126/science.1198469
   HONDA, ET AL: "Regulation of T Cell Responses by Intestinal Cornmensal Bacteria", J. INTEST. MICROBIOL, vol. 25, no. 2, 1 January 2011 (2011-01-01), pages 104, XP055402357
   BORODY T J, ET AL: "Treatment of ulcerative colitis using fecal bacteriotherapy", JOURNAL OF CLINICAL GASTROENTEROLOGY., RAVEN PRESS LTD., NEW YORK, NY., US, vol. 37, no. 1, 1 January 2003 (2003-01-01), US , pages 42 - 47, XP008093566, ISSN: 0192-0790, DOI: 10.1097/00004836-200307000-00012

DOI:   http://dx.doi.org/10.1097/00004836-200307000-00012
   BIDDLE AMY S., ET AL: "The complete genome sequence of Clostridium indolis DSM 755T", STANDARDS IN GENOMIC SCIENCES, vol. 9, no. 3, 1 January 2014 (2014-01-01), pages 1089 - 1104, XP055981585, DOI: 10.4056/sigs.5281010

DOI:   http://dx.doi.org/10.4056/sigs.5281010
   HAYASHI H, SAKAMOTO M, BENNO Y: "Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods", MICROBIOLOGY AND IMMUNOLOGY, CENTER FOR ACADEMIC PUBLICATIONS JAPAN|, JP, vol. 46, no. 8, 1 January 2002 (2002-01-01), JP , pages 535 - 548, XP003017192, ISSN: 0385-5600
   SGHIR ABDELGHANI ET AL: "Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization.", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 66, no. 5, 1 May 2000 (2000-05-01), US , pages 2263 - 2266, XP002166836, ISSN: 0099-2240, DOI: 10.1128/AEM.66.5.2263-2266.2000

DOI:   http://dx.doi.org/10.1128/AEM.66.5.2263-2266.2000
   ITOH K, MITSUOKA T: "Characterization of clostridia isolated from faeces of limited flora mice and their effect on caecal size when associated with germ-free mice", LABORATORY ANIMALS., LABORATORY ANIMALS, LONDON., GB, vol. 19, no. 2, 1 April 1985 (1985-04-01), GB , pages 111 - 118, XP002657282, ISSN: 0023-6772
   GABORIAU-ROUTHIAU ET AL.: "The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T cell Responses", IMMUNITY, vol. 31, no. 4, October 2009 (2009-10-01), pages 677 - 689, XP055005245, DOI: 10.1016/j.immuni.2009.08.020

DOI:   http://dx.doi.org/10.1016/j.immuni.2009.08.020
   SOKOL ET AL.: "Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 105, no. 43, 2008, pages 16731 - 16736, XP002579466, DOI: 10.1073/PNAS.0804812105

DOI:   http://dx.doi.org/10.1073/PNAS.0804812105
   KARIMI ET AL.: "Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice", AM J RESPIR CRIT CARE MED, vol. 179, no. 3, 1 February 2009 (2009-02-01), pages 186 - 93, XP055005126, DOI: 10.1164/rccm.200806-951OC

DOI:   http://dx.doi.org/10.1164/rccm.200806-951OC
   ITOH K. ET AL.: "Characterization of clostridia isolated from faeces of limited flora mice and their effect on caecal size when associated with germ-free mice", LAB. ANIMALS, vol. 19, 1985, pages 111 - 118, XP002657282
   CLAVEL ET AL.: "Survival of Bacillus cereus spores and vegetative cells in acid media simulating human stomach", JOURNAL OF APPLIED MICROBIOLOGY, vol. 97, pages 214 - 219, XP055365130, DOI: 10.1111/j.1365-2672.2004.02292.x

DOI:   http://dx.doi.org/10.1111/j.1365-2672.2004.02292.x
   K. ATARASHI, T. TANOUE, T. SHIMA, A. IMAOKA, T. KUWAHARA, Y. MOMOSE, G. CHENG, S. YAMASAKI, T. SAITO, Y. OHBA, T. TANIGUCHI, K. TA: "Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, vol. 331, no. 6015, 21 January 2011 (2011-01-21), pages 337 - 341, XP055005026, ISSN: 00368075, DOI: 10.1126/science.1198469

DOI:   http://dx.doi.org/10.1126/science.1198469
   HONDA, ET AL: "Regulation of T Cell Responses by Intestinal Cornmensal Bacteria", J. INTEST. MICROBIOL, vol. 25, no. 2, 1 January 2011 (2011-01-01), pages 104, XP055402357
   RICHARD S. ABRAMS: "Open Label, Uncontrolled Trial of Bowel Sterilization and Repopulation with Normal Bowel Flora for Treatment of Inflammatory Bowel Disease", CURRENT THERAPEUTIC RESEARCH, vol. 58, no. 12, December 1997 (1997-12-01), pages 1001 - 1012, XP000973146, DOI: 10.1016/S0011-393X(97)80067-7

DOI:   http://dx.doi.org/10.1016/S0011-393X(97)80067-7
   BORODY ET AL.: "Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy", JOURNAL OF CLINICAL GASTROENTEROLOGY, vol. 37, no. 1, 2003, pages 42 - 47, XP008093566, DOI: 10.1097/00004836-200307000-00012

DOI:   http://dx.doi.org/10.1097/00004836-200307000-00012
   MOMOSE ET AL.: "16S rRNA gene sequence-based analysis of clostridia related to conversion of germfree mice to the normal state", JOURNAL OF APPLIED MICROBIOLOGY, vol. 107, 2009, pages 2088 - 2097, XP055402299, DOI: 10.1111/j.1365-2672.2009.04431.x

DOI:   http://dx.doi.org/10.1111/j.1365-2672.2009.04431.x
   HAYASHI ET AL.: "Phylogenetic Analysis of the Human Gut Microbiota Using 16S rDNA Clone Libraries and Strictly Anaerobic Culture-Based Methods", MICROBIOL. IMMUNOL., vol. 46, 2002, pages 535 - 548, XP003017192
   SGHIR ET AL.: "Quantification of Bacterial Groups within Human Fecal Flora by Oligonucleotide Probe Hybridization", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 66, no. 5, 2000, pages 2263 - 2266, XP002166836, DOI: 10.1128/AEM.66.5.2263-2266.2000

DOI:   http://dx.doi.org/10.1128/AEM.66.5.2263-2266.2000
   COLLINS ET AL.: "The phylogeny of the genus Clostridium: Proposal of five new Genera and eleven new species combinations", INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, October 1994 (1994-10-01), pages 812 - 826, XP055107539, DOI: 10.1099/00207713-44-4-812

DOI:   http://dx.doi.org/10.1099/00207713-44-4-812
   ATARASHI ET AL.: "Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota", NATURE, vol. 500, no. 7461, August 2013 (2013-08-01), pages 232 - 236, XP055178303, DOI: 10.1038/nature12331

DOI:   http://dx.doi.org/10.1038/nature12331
   FRANK ET AL.: "Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases", PNAS, vol. 104, no. 34, 2007, pages 13780 - 13785, XP055050956, DOI: 10.1073/pnas.0706625104

DOI:   http://dx.doi.org/10.1073/pnas.0706625104
   MARTIN ET AL.: "The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS- induced chronic moderate and severe colitis models", INFLAMM BOWEL DIS, vol. 20, no. 3, March 2014 (2014-03-01), pages 417 - 30, XP009191583, DOI: 10.1097/01.MIB.0000440815.76627.64

DOI:   http://dx.doi.org/10.1097/01.MIB.0000440815.76627.64
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.